Jayson Donald Alexander Dallas - 11 Jun 2021 Form 4 Insider Report for ARENA PHARMACEUTICALS INC

Role: Director
Signature: /s/ Andrew J. Cronauer, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 11 Jun 2021
Net transactions value: -$81,158
Form type: 4
Filing time: 15 Jun 2021, 17:27:35 UTC
Previous filing: 28 May 2021
Next filing: 11 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARNA	Common Stock	Award	$0	+3,067	+58%	$0.000000	8,375	11 Jun 2021	Direct	F1
transaction	ARNA	Common Stock	Sale	$81,158	-1,223	-15%	$66.36	7,152	15 Jun 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARNA	Stock Option (right to buy)	Award	$0	+7,202		$0.000000	7,202	11 Jun 2021	Common Stock	7,202	$65.19	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount represents restricted stock units that vest in full on the earliest of June 11, 2022, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
F2	The transactions reported in this line item of this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
F3	The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 11, 2021 with the final installment vesting upon the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders' meeting, and are exercisable once vested.